<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0300-9041</journal-id>
<journal-title><![CDATA[Ginecología y obstetricia de México]]></journal-title>
<abbrev-journal-title><![CDATA[Ginecol. obstet. Méx.]]></abbrev-journal-title>
<issn>0300-9041</issn>
<publisher>
<publisher-name><![CDATA[Federación Mexicana de Colegios de Obstetricia y Ginecología A.C.]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0300-90412020000100007</article-id>
<article-id pub-id-type="doi">10.24245/gom.v88i1.1972</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Linfoma de Hodgkin durante el embarazo: reporte de un caso]]></article-title>
<article-title xml:lang="en"><![CDATA[Hodgkin lymphoma in the pregnancy: A case report]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Reyna-Castelán]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Robledo-Márquez]]></surname>
<given-names><![CDATA[Sandra Nayeli]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[López-Salazar]]></surname>
<given-names><![CDATA[Dafne Andrea]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado Ginecología endocrina e Infertilidad ]]></institution>
<addr-line><![CDATA[Tultitlán Estado de México]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Estudios Superiores Iztacala ]]></institution>
<addr-line><![CDATA[ Estado de México]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2020</year>
</pub-date>
<volume>88</volume>
<numero>1</numero>
<fpage>41</fpage>
<lpage>47</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S0300-90412020000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S0300-90412020000100007&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S0300-90412020000100007&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  ANTECEDENTES: El linfoma de Hodgkin ocupa el cuarto lugar de las neoplasias que aparecen durante el embarazo. En realidad, éste no tiene repercusiones en la historia natural de la enfermedad, pero dificulta el tratamiento.  CASO CLÍNICO: Paciente de 18 años, con 35 semanas de embarazo; ingresó al servicio de Ginecología Oncológica por aumento de volumen en la región axilar derecha, con dolor a la palpación profunda. Durante la exploración se observó un ganglio móvil de 3 x 3.5 cm en el lado derecho de la región axilar y adenopatía inguinal izquierda, menor de 1 cm. La ecografía reportó la mama derecha con una masa sólida, homogénea, de bordes nítidos, de 38 x 35 mm y volumen de 20.84 cc; el Doppler color evidenció aumento de la vascularización. La lesión se estadificó en BIRADS 3. Se decidió finalizar el embarazo por cesárea, con nacimiento de un varón sano, de 2900 g, Apgar 8/9. De la biopsia se extrajeron ocho ganglios linfáticos axilares. La inmunohistoquímica confirmó un proceso linfoproliferativo, compatible con linfoma de Hodgkin clásico, con celularidad mixta CD30+ y KI67 50%. Se le indicó quimioterapia con protocolo ABVD en 6 ciclos, sin necesidad de radioterapia. A seis meses de la cirugía su evolución fue satisfactoria, con ausencia de ganglios palpables, sin recidiva ni reacción fallida a los medicamentos.  CONCLUSIÓN: El linfoma de Hodgkin concomitante con el embarazo es excepcional; los signos de la enfermedad pueden confundirse fácilmente con otras alteraciones, incluso pasar inadvertidas. El feto, al exponerse a radiación menor a 100 mGy, tiene menos posibilidades de malformaciones.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  BACKGROUND: Hodgkin lymphoma during pregnancy accounts for 4th place in the neoplasms. Pregnancy has no impact on the natural history of the disease; however, it hinders treatment, which is individualized from a clinical evaluation and based on staging.  CLASSIC CASE:  Patient 18 years of age, with pregnancy of 35 weeks gestation, who is referred to the external consultation of Oncology Gynecology by increased volume in right axillary region with deep palpation pain. During its examination presence of 3 x 3.5 cm mobile node, on the right side of the axillary region, and left inguinal adenopathy &gt;1 cm. The ultrasound reported right breast with solid mass, homogeneous, sharp edges, 38 x 35 mm and volume of 20.84 cc, doppler color with increased vascularity, is staged as BIRADS 3. Cesarean section was performed, with male birth, weight; 2900 g Apgar 8/9 without incident report. In the periareolar excisional biopsy, eight axillary lymph nodes were removed. Immunohistochemistry confirmed a classic LH-compatible lymphoproliferative process with CD30+, KI67 50% mixed cellularity. The hematology service decides management based on chemotherapy with ABVD protocol in 6 blocks, without radiotherapy. Currently it is evolving smoothly after six months of surgery, there was no corroborate of palpable nodes, and so far treatment, without reports of relapses or reaction to medications.  CONCLUSION: Hodgkin´s lymphoma in pregnancy is exceptional, the signs of the disease are easily confused with other pathologies or even go unnoticed. The fetus, when exposed to radiation less than 100 mgy, is less likely to malform.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Linfoma de Hodgkin]]></kwd>
<kwd lng="es"><![CDATA[embarazo]]></kwd>
<kwd lng="es"><![CDATA[ganglio linfático axilar]]></kwd>
<kwd lng="es"><![CDATA[cesárea]]></kwd>
<kwd lng="es"><![CDATA[protocolo ABVD]]></kwd>
<kwd lng="en"><![CDATA[Hodgkin lymphoma]]></kwd>
<kwd lng="en"><![CDATA[Pregnancy]]></kwd>
<kwd lng="en"><![CDATA[Axilary lymph nodes]]></kwd>
<kwd lng="en"><![CDATA[Cesarean section]]></kwd>
<kwd lng="en"><![CDATA[ABVD protocol]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Monleón]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cáncer y gestación]]></article-title>
<source><![CDATA[Clin Invest Gin Obst]]></source>
<year>2006</year>
<volume>33</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>80-92</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="">
<collab>National Cancer Institute</collab>
<source><![CDATA[Diccionario de cáncer]]></source>
<year>2019</year>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lozano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad de Hodking]]></article-title>
<source><![CDATA[Offarm]]></source>
<year>2002</year>
<volume>21</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>114-8</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kassab]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin&#8217;s disease and pregnancy: case series and proposal for treatment protocol]]></article-title>
<source><![CDATA[Einstein]]></source>
<year>2011</year>
<volume>9</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>216-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Córdoba]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma no Hodgkin agresivo durante el embarazo]]></article-title>
<source><![CDATA[Rev Med Urug]]></source>
<year>2010</year>
<volume>26</volume>
<page-range>102-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fisher]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Pregnancy Does Not Increase Risk of Hodgkin Lymphoma Relapse]]></article-title>
<source><![CDATA[ASCO]]></source>
<year>2015</year>
</nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Froesch]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin and Non-Hodgkin lymphomas during pregnancy]]></article-title>
<source><![CDATA[Cancer Preg]]></source>
<year>2008</year>
<volume>178</volume>
<page-range>111-21</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Koren]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer in Pregnancy and Lactation]]></source>
<year>2011</year>
<page-range>75-95</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ansell]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin lymphoma: 2016 update on diagnosis, risk-stratification, and management]]></article-title>
<source><![CDATA[Am J Hematol]]></source>
<year>2016</year>
<volume>91</volume>
<page-range>434-40</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gideon]]></surname>
<given-names><![CDATA[K.]]></given-names>
</name>
</person-group>
<source><![CDATA[Cancer in pregnancy and lactation: The Motherisk Guide]]></source>
<year>2011</year>
<page-range>18-20</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Cambridge University Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zerga]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Tratamiento del Hodgkin en situaciones particulares]]></article-title>
<source><![CDATA[Hematología]]></source>
<year>2016</year>
<volume>20</volume>
<page-range>107-17</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazcano]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Marcadores tumorales]]></article-title>
<source><![CDATA[Rev Clin Med Fam]]></source>
<year>2016</year>
<volume>9</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-42</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Benardete-Harar]]></surname>
<given-names><![CDATA[D.]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso de quimioterapia durante el embarazo]]></article-title>
<source><![CDATA[Rev Med Inst Mex Seguro Soc]]></source>
<year>2016</year>
<volume>54</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>752-8</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Imaging for staging and response assessment in lymphoma]]></article-title>
<source><![CDATA[Radiology]]></source>
<year>2015</year>
<volume>276</volume>
<page-range>323-38</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<collab>Guía de Práctica Clínica</collab>
<article-title xml:lang=""><![CDATA[Diagnostico y tratamiento del cáncer de mama en segundo y tercer nivel de atención]]></article-title>
<source><![CDATA[Secretaria de Salud]]></source>
<year>2009</year>
<volume>1</volume>
<page-range>102</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bellas]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Linfoma Hodgkin]]></article-title>
<source><![CDATA[Rev Esp Patol]]></source>
<year>2004</year>
<volume>37</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>129-38</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lara]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Diagnóstico histopatológico e inmunohistoquímico del linfoma de Hodgkin y su diagnóstico diferencial]]></article-title>
<source><![CDATA[Rev Lat Patologia]]></source>
<year>2009</year>
<volume>47</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>35-45</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eyre]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<source><![CDATA[Management and controversies of classical hodgkin lymphoma in pregnancy]]></source>
<year>2015</year>
<volume>169</volume>
<page-range>613-30</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Eichenauer]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up]]></article-title>
<source><![CDATA[Ann Oncol]]></source>
<year>2018</year>
<volume>29</volume>
</nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bachanova]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin Lymphoma in Pregnancy]]></article-title>
<source><![CDATA[Current Hematologic Malignancy Reports]]></source>
<year>2013</year>
<volume>8</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>211-7</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="book">
<source><![CDATA[Publicación ICRP-84 Embarazo e Irradiaciòn Mèdica]]></source>
<year>2000</year>
<publisher-name><![CDATA[Comisión Internacional de Protección Radiológicas]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kassab]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Hodgkin&#8217;s disease and pregnancy: case series and proposal for treatment protocol]]></article-title>
<source><![CDATA[Einstein]]></source>
<year>2011</year>
<volume>9</volume>
<page-range>216-9</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rueda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Linfoma de Hodgkin]]></source>
<year>2019</year>
<publisher-name><![CDATA[Sociedad Española de Oncología Médica]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The Management of Classical Hodgkin&amp;apos;s Lymphoma: Past, Present, and Future]]></article-title>
<source><![CDATA[Advances Hematol]]></source>
<year>2011</year>
</nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Follows]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guidelines for the first line management of classical Hodgkin lymphoma]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2014</year>
<volume>166</volume>
<page-range>34-49</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
